A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...

Researchers at the University of Vienna have developed gut-stable oxytocin analogues designed for targeted treatment of ...

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral ...

Researchers at the University of Vienna develop gut-specific oxytocin analogs, providing an innovative therapeutic option ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...

A team of researchers at the University of Vienna, headed by medicinal chemist Markus Muttenthaler, has created a novel class of oral peptide therapies for managing chronic abdominal pain.

Austrian researchers have developed an oxytocin drug that is stable in the gut for those who have abdominal pain. This is a ...

We preselected all newsletters you had before unsubscribing.

Researchers at the University of Vienna develop gut-stable oxytocin analogues for targeted pain treatment of chronic abdominal painA research team at ...